The current valuation score of Sutro Biopharma Inc is 7.07, ranking 219 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -1.48, which is -87.92% below the recent high of -0.18 and -142.37% above the recent low of -3.60.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.